Ketamine

• A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major d… Not authorised
  2022-502185-24-00 Phase III 4 countries University Medical Center Utrecht
• Efficacy of Ketamine for the Prevention of Relapse in Patients with Opioid-Use Disorders (OUD) Pending
  2025-520843-34-00 Phase II 1 country University of Cyprus
• Efficacy and safety of Remimazolam compared to Ketamine and Propofol in Rapid Sequence Induction. A monocentric pilot randomised-controlled … Pending
  2025-521602-18-00 Phase II 1 country Centre Hospitalier Universitaire De Nantes
• Evaluation of postoperative recovery when combining intravenous lidocaine with ropivacaine infiltration in laparoscopic colorectal oncologic… Recruiting
  2025-523207-29-00 Phase IV 1 country Centre Hospitalier Universitaire Amiens Picardie
• RANDOMIZED CONTROLLED STUDY COMPARING SUFENTANIL AND KETAMINE INTRANASALLY IN THE MANAGEMENT OF SEVERE ACUTE TRAUMA-RELATED PAIN IN CHILDREN Recruiting
  2025-521075-31-00 Phase II 1 country Fondation Lenval Nice
• Best hypnotic drug choice for rapid sequence induction in the operating room: a 3-arm randomized trial open-labelled with blinded evaluation… Recruiting
  2024-517582-16-00 Phase III 1 country Centre Hospitalier Universitaire De Nantes
• AntaMIn - Pain reduction for limb injuries in pediatric emergency departments: A Randomised Clinical Trial comparing intranasal Fentanyl or … Recruiting
  2023-506803-25-01 Phase II/III 1 country Assistance Publique Hopitaux De Paris
• Ketamine for depression and alcohol use disorder Recruiting
  2023-506052-24-00 Phase I/II 1 country University Hospital Of North Norway HF
• Early efficacy of ketamine compared to placebo, in add-on therapy of venlafaxine for inpatients with severe unipolar major depressive episod… Recruiting
  2023-506597-12-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for major depressive disorder c… Recruiting
  2023-506617-21-00 Phase III 5 countries Universitair Medisch Centrum Utrecht
• Ketamine therapy in obsessive-compulsive disorder and its effects on neuropsychological function under stress in a cross-over trial Recruiting
  2024-518212-40-00 Phase III 1 country Medical University Of Vienna
• Brain Injury and Ketamine: a prospective, randomized controlled double blind clinical trial to study the effects of ketamine on therapy inte… Recruiting
  2023-505319-19-00 Phase III/IV 1 country UZ Leuven
• Ketamine to treat patients with post-comatose disorders of consciousness Halted
  2024-518433-29-00 Phase II 1 country Centre Hospitalier Universitaire De Liege; Universite De Liege

Showing 1–13 of 13 trials